GIA
ANIK icon

GHP Investment Advisors’s Anika Therapeutics ANIK Stock Holding History

GHP Investment Advisors’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$638 Buy
+44
New +$511 ﹤0.01% 1086

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

GHP Investment Advisors's ANIK Position: Q1 2026 in Review

GHP Investment Advisors opened a new position in Anika Therapeutics (ANIK) in Q1 2026: 44 shares worth $638. The stake represents ﹤0.01% of the portfolio and ranks #1086 among its holdings.

130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • GHP Investment Advisors held 44 shares of Anika Therapeutics worth $638 as of Q1 2026.
  • Anika Therapeutics was a new GHP Investment Advisors position in Q1 2026.
  • Anika Therapeutics made up ﹤0.01% of GHP Investment Advisors's portfolio in Q1 2026, its #1086 holding.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on GHP Investment Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.